MedPath

PROVIDENCE HEALTH & SERVICES - OREGON

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Safety/Effectiveness of Adding Monthly Dexamethasone to Weekly Avonex for MS

Completed
Conditions
Relapsing-remitting Multiple Sclerosis
Clinically Isolated Syndrome
First Posted Date
2005-10-04
Last Posted Date
2011-07-22
Lead Sponsor
Providence Multiple Sclerosis Center
Target Recruit Count
40
Registration Number
NCT00232193
Locations
🇺🇸

Providence MS Center, Portland, Oregon, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.